Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock

Replimune stock cratered Tuesday after the Food and Drug Administration unexpectedly rejected its experimental melanoma treatment.

Investors Business Daily

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

The Independent UK

AstraZeneca To Invest $50 Bn In The US As Tariff Threat Looms

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald Trump's threats to impose tariffs on the sector.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca pledges $50bn US investment ahead of drugs tariffs

Donald Trump is expected to announce tariffs of up to 200% on drugs makers in August

Evening Standard

AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats

UK company to fund new drug manufacturing facility in Virginia and expand R&D facilities around US

The Guardian - UK

Rachel Reeves vows to stick to fiscal rules and declines to rule out wealth tax – as it happened

Rolling coverage of the latest economic and financial news, as chancellor Rachel Reeves testifies to House of Lords economic affairs committee

The Guardian - UK

Major HRT supplier sanctioned after whistleblowers raise concerns over patient safety

A group of employees from Theramex, which supplies HRT treatments to millions of patients in the UK, wrote a letter to the pharmaceutical regulator

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Why Alkermes Tumbled On Its Positive Narcolepsy Study

Alkermes stock skidded Monday on the back of mixed results for its experimental narcolepsy treatment, an orexin agonist.

Investors Business Daily

FDA names former pharmaceutical company executive to oversee US drug program

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program

The Independent UK

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene therapy

The Independent UK

US Authorizes Juul To Market Vaping Products

Juul Labs said Thursday that the US Food and Drug Administration had officially authorized the e-cigarette maker to market its vaping system and refill capsules in the United States.

International Business Times

Arcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%

Arcutis stock is setting up in a base with the company's earnings report due around mid-August.

Investors Business Daily

Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock

This cancer treatment stock is nearing a buy point of a base. Shares have already gained 50% so far this year.

Investors Business Daily

Will Trump's Looming Tariffs Affect Pharma Profits In The Second Half Of 2025?

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Amgen: How To Find And Own America's Greatest Opportunities

From Amgen's classic double-bottom base in February 1990 until it ultimately topped in the summer of 2000, it increased more than 50 times.

Investors Business Daily

Trump Threatens Up To 200% Tariffs On Drug Imports. The Market Doesn't Believe Him.

President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon."

Evening Standard

Government suing PPE Medpro because of ‘buyer’s remorse’, court told

The Department of Health and Social Care wants PPE Medpro to repay more than £120 million over an alleged breach of contract.

AAP

At-home drug test offers workers more autonomy

Simple at-home drug testing kits are helping employees "do the right thing before it becomes a problem", their creators say.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

If AstraZeneca goes to the US, it will be a major blow for London and Labour

Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy

The Independent UK

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate

Investors Business Daily

Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind

Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.

Investors Business Daily

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?

Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.

Latin Times

Federal Watchdog Slams CBP for Mismanaging Millions in Tech Aimed To Detect Fentanyl at Border

A report found that of 361 systems installed since 2019, 166 (46%) were inoperable at some point, sometimes for as long as 344 days, resulting in more than 400,000 hours of downtime

Evening Standard

Risk to patient health from drug shortages is ‘distressing new normal’

Medicine shortages are causing unprecedented issues for patients, Community Pharmacy England said.

Investors Business Daily

Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care

Gilead Sciences shares rose Friday after the Supreme Court tossed out a challenge that would have impacted HIV PrEP drugs.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

the Food and Drug Administration

201 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.